Related Experiment Video
Updated: Mar 7, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Obesity Epidemic: Pharmaceutical Weight Loss
1Division of Endocrinology, Diabetes and Metabolism, CharterCARE Medical Associates, Providence RI.
Rhode Island Medical Journal (2013)
|March 2, 2017
Summary
Obesity, a chronic disease defined by excess adipose tissue (BMI > 30), is increasingly managed with new pharmaceutical options since 2012. Effective treatment requires a multidisciplinary approach focusing on lifestyle changes for sustained weight loss.
Area of Science:
- Medical Science
- Endocrinology
- Public Health
Background:
- Obesity is a chronic disease characterized by excess adipose tissue, defined by a body mass index (BMI) exceeding 30.0 kg/m2.
- Increased awareness of obesity prevention has driven the development of new pharmaceutical treatments since 2012.
- Current obesity management emphasizes an individualized, multidisciplinary strategy.
Purpose of the Study:
- To review the advancements in pharmaceutical options for obesity treatment.
- To highlight the importance of a comprehensive approach to managing obesity.
- To underscore the role of lifestyle modifications in maintaining weight loss.
Main Methods:
- Literature review of pharmaceutical interventions for obesity.
- Analysis of multidisciplinary treatment strategies.
- Discussion of lifestyle factors in weight management.
Main Results:
- Several new pharmaceutical agents for obesity have become available since 2012.
- A combination of medication and lifestyle changes offers a promising approach.
- Sustained weight loss is achievable through integrated care and supportive lifestyle adjustments.
Conclusions:
- Pharmaceutical interventions represent a significant advancement in obesity treatment.
- An individualized, multidisciplinary approach is crucial for successful obesity management.
- Long-term success in weight management depends on sustained lifestyle changes and ongoing support.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
331
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
331
01:21Drug Dosing: Obese Patients
320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:02Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K